Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.7)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 4, April, p. 475–480

doi: 10.17219/acem/116758

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Evaluation of the relationship between splenic iron overload and liver, heart and muscle features evident on T2*-weighted magnetic resonance imaging

Mehmet Güli Çetinçakmak1,A,B,C,D,E, Salih Hattapoğlu1,A,B,D, Murat Söker2,B,C, Faysal Ekici1,A,B,D, Kamil Yilmaz2,B,C, Cemil Göya1,A,B,C, Cihad Hamidi1,A,D,E,F

1 Department of Radiology, Medical School, Dicle University, Diyarbakir, Turkey

2 Department of Pediatrics, Medical School, Dicle University, Diyarbakir, Turkey

Abstract

Background. Splenic iron overload is the most common clinical condition in patients with thalassemia. However, few studies of the effects of splenectomy have been published.
Objectives. To evaluate the relationship between splenic iron overload and liver, heart and muscle features visible in T2*-weighted magnetic resonance imaging, and to investigate the effects of splenectomy on these tissues in patients with beta-thalassemia major (TM).
Material and Methods. We retrospectively included 131 patients (76 male and 55 female) diagnosed with TM. All radiological assessments were performed with the aid of a Philips Achieva 1.5T scanner running a multiecho gradient-echo sequence. Hepatic and splenic T2* values were assessed in the same gradient multiecho series. Muscle T2* values were assessed in the shoulder girdle muscles adjacent to the heart area. The relationships among splenic T2*, hepatic T2*, cardiac T2* and muscle T2* parameters, serum ferritin levels, age and other parameters were evaluated.
Results. The splenic T2* value correlated with serum ferritin level and the hepatic T2* value (p < 0.001 and p < 0.001, respectively). The splenic T2* value did not correlate with age, cardiac or muscle T2* values, or with spleen size (p = 0.27, 0.21, 0.99, and 0.39, respectively). The muscle T2* value correlated weakly with the serum ferritin level (p = 0.022). The cardiac T2* value was lower and the liver size greater in patients who had undergone splenectomy compared with those who had not (p < 0.001 and 0.001, respectively).
Conclusion. Splenic iron overload correlated with hepatic overload and the serum ferritin level. Splenectomy increased cardiac iron overload and triggered liver enlargement. However, the muscle iron overload was low and the muscles were therefore unaffected by splenectomy.

Key words

spleen, iron overload, MR imaging, thalassemia

References (22)

  1. Ganz T. Molecular control of iron transport. J Am SocNephrol. 2007;18(2):394–400.
  2. Morgan EH, Walters MNI. Iron storage in human disease. J Clin Pathol. 1963;16(2):101–107.
  3. Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: Should we revisit the indications? Br J Haematol. 2012;158(1):16–29.
  4. Garbowski MW, Carpenter JP, Smith G, et al. Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson. 2014;16:40.
  5. Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113(20):4853–4855.
  6. Wood JC. Guidelines for quantifying iron overload. ASH Educ Program Book. 2014;2014(1):210–215.
  7. Christoforidis A, Haritandi A, Tsatra I, Tsitourides I, Karyda S, Athanassiou-Metaxa M. Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with β-thalassaemia major: Comparison between different chelation regimens. Eur J Haematol. 2007;78(1):52–57.
  8. Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC. Longitudinal analysis of heart and liver iron in thalassemia major. Blood. 2008;112(7):2973–2978.
  9. Carpenter JP, Roughton M, Pennell DJ. International survey of T2* cardiovascular magnetic resonance in β-thalassemia major. Haemato­logica. 2013;98(9):1368–1374.
  10. Wang ZJ, Fischer R, Chu Z, et al. Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging. 2010;28(3):363–371.
  11. Papakonstantinou O, Drakonaki EE, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N. MR imaging of spleen in beta-thalassemia major. Abdom Imaging. 2015;40(7):2777–2782.
  12. Brewer CJ, Coates TD, Wood JC. Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major. JMRI. 2009;29(2):357–364.
  13. Kolnagou A, Natsiopoulos K, Kleanthous M, Ioannou A, Kontoghiorghes GJ. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: Factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*. Toxicol Mech Methods. 2013;23(1):48–56.
  14. Papakonstantinou O, Alexopoulou E, Economopoulos N, et al. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major. J Magn Reson Imaging. 2009; 29(4):853–859.
  15. Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. WJG. 2010;16(13):1587–1597.
  16. Siegelman ES, Mitchell DG Semelka RC. Abdominal iron deposition: Metabolism, MR findings, and clinical importance. Radiology. 1996;199(1):13–22.
  17. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. The Lancet. 2004;363(9406):357–362.
  18. Wood JC. Estimating tissue iron burden: Current status and future prospects. Br J Haematol. 2015;170(1):15–28.
  19. Matter RM, Allam KE, Sadony AM. Gradient-echo magnetic resonance imaging study of pancreatic iron overload in young Egyptian beta-thalassemia major patients and effect of splenectomy. Diabetol Metab Syndr. 2010;2:23.
  20. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
  21. Queiroz-Andrade M, Blasbalg R, Ortega CD, et al. MR imaging findings of iron overload. Radiogr Rev Publ Radiol Soc N Am Inc. 2009;29(6):1575–1589.
  22. Westphalen ACA, Qayyum A, Yeh BM, et al. Liver fat: Effect of hepa­tic iron deposition on evaluation with opposed-phase MR imaging. Radiology. 2007;242(2):450–455.
© Wroclaw Medical University